Eperisone is an antispasmodic drug which relaxes both skeletal muscles and vascular smooth muscles, and demonstrates a variety of effects such as reduction of myotonia, improvement of circulation, and suppression of the pain reflex. It is not approved for use in the United States, but is available in other countries like India, South Korea, and Bangladesh.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Eperisone may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Eperisone may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Eperisone. |
| Buprenorphine | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Eperisone. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Eperisone. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Eperisone. |
| Hydrocodone | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Magnesium sulfate | The therapeutic efficacy of Eperisone can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Eperisone may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Eperisone. |
| Mirtazapine | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Eperisone. |
| Orphenadrine | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Eperisone. |
| Pramipexole | Eperisone may increase the sedative activities of Pramipexole. |
| Ropinirole | Eperisone may increase the sedative activities of Ropinirole. |
| Rotigotine | Eperisone may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Eperisone. |
| Sodium oxybate | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Eperisone. |
| Thalidomide | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Cimetidine | The serum concentration of Eperisone can be increased when it is combined with Cimetidine. |
| Clopidogrel | The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Eperisone. |
| Efavirenz | The serum concentration of Eperisone can be decreased when it is combined with Efavirenz. |
| Melatonin | The therapeutic efficacy of Eperisone can be decreased when used in combination with Melatonin. |
| Nafcillin | The therapeutic efficacy of Eperisone can be decreased when used in combination with Nafcillin. |
| Nitroprusside | Eperisone may increase the hypotensive activities of Nitroprusside. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Eperisone. |
| Dantrolene | The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Eperisone. |
| Lithium citrate | The risk or severity of adverse effects can be increased when Eperisone is combined with Lithium citrate. |
| Lithium carbonate | The risk or severity of adverse effects can be increased when Eperisone is combined with Lithium carbonate. |
| Lithium hydroxide | The risk or severity of adverse effects can be increased when Eperisone is combined with Lithium hydroxide. |
| Methocarbamol | The risk or severity of visual accommodation disturbances can be increased when Eperisone is combined with Methocarbamol. |
| Boceprevir | The serum concentration of Eperisone can be increased when it is combined with Boceprevir. |
| Ethanol | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Eperisone may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Eperisone. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Eperisone is combined with Fluvoxamine. |
| Duloxetine | The risk or severity of adverse effects can be increased when Eperisone is combined with Duloxetine. |
| Paroxetine | The risk or severity of adverse effects can be increased when Eperisone is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Eperisone is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Eperisone is combined with Sibutramine. |
| Zimelidine | The risk or severity of adverse effects can be increased when Eperisone is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Eperisone is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Eperisone is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Eperisone is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Eperisone is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Eperisone is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Eperisone is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Eperisone is combined with Alaproclate. |
| Tocainide | Tocainide may increase the arrhythmogenic activities of Eperisone. |
| Aprindine | Aprindine may increase the arrhythmogenic activities of Eperisone. |
| Xylometazoline | Xylometazoline may increase the arrhythmogenic activities of Eperisone. |
| Sparteine | Sparteine may increase the arrhythmogenic activities of Eperisone. |
| Fasudil | Fasudil may increase the arrhythmogenic activities of Eperisone. |
| Carteolol | Eperisone may increase the arrhythmogenic activities of Carteolol. |
| Metipranolol | Eperisone may increase the arrhythmogenic activities of Metipranolol. |
| Spiradoline | Eperisone may increase the arrhythmogenic activities of Spiradoline. |
| Tiracizine | Eperisone may increase the arrhythmogenic activities of Tiracizine. |
| Ethacizine | Eperisone may increase the arrhythmogenic activities of Ethacizine. |
| Hydroquinine | Eperisone may increase the arrhythmogenic activities of Hydroquinine. |
| Bioallethrin | Eperisone may increase the arrhythmogenic activities of Bioallethrin. |
| Fosfructose | Eperisone may increase the arrhythmogenic activities of Fosfructose. |
| Hydroquinidine | Eperisone may increase the arrhythmogenic activities of Hydroquinidine. |
| SOR-C13 | Eperisone may increase the arrhythmogenic activities of SOR-C13. |
| Digoxin | Digoxin may increase the arrhythmogenic activities of Eperisone. |
| Acetyldigitoxin | Acetyldigitoxin may increase the arrhythmogenic activities of Eperisone. |
| Deslanoside | Deslanoside may increase the arrhythmogenic activities of Eperisone. |
| Cymarin | Eperisone may increase the arrhythmogenic activities of Cymarin. |
| Metildigoxin | Eperisone may increase the arrhythmogenic activities of Metildigoxin. |
| Acetyldigoxin | Eperisone may increase the arrhythmogenic activities of Acetyldigoxin. |
| Disopyramide | Disopyramide may increase the arrhythmogenic activities of Eperisone. |
| Ibutilide | Ibutilide may increase the arrhythmogenic activities of Eperisone. |
| Procainamide | Procainamide may increase the arrhythmogenic activities of Eperisone. |
| Bepridil | Bepridil may increase the arrhythmogenic activities of Eperisone. |
| Terodiline | Eperisone may increase the arrhythmogenic activities of Terodiline. |
| Diltiazem | Diltiazem may increase the arrhythmogenic activities of Eperisone. |
| Nimodipine | Nimodipine may increase the arrhythmogenic activities of Eperisone. |
| Cinnarizine | Cinnarizine may increase the arrhythmogenic activities of Eperisone. |
| Atropine | Atropine may increase the arrhythmogenic activities of Eperisone. |
| Adenosine | Adenosine may increase the arrhythmogenic activities of Eperisone. |
| Levosimendan | Levosimendan may increase the arrhythmogenic activities of Eperisone. |
| Nifedipine | Nifedipine may increase the arrhythmogenic activities of Eperisone. |
| Flecainide | Flecainide may increase the arrhythmogenic activities of Eperisone. |
| Prenylamine | Prenylamine may increase the arrhythmogenic activities of Eperisone. |
| Fluspirilene | Fluspirilene may increase the arrhythmogenic activities of Eperisone. |
| Azimilide | Azimilide may increase the arrhythmogenic activities of Eperisone. |
| Tedisamil | Tedisamil may increase the arrhythmogenic activities of Eperisone. |
| Nilvadipine | Nilvadipine may increase the arrhythmogenic activities of Eperisone. |
| Fendiline | Fendiline may increase the arrhythmogenic activities of Eperisone. |
| Benidipine | Eperisone may increase the arrhythmogenic activities of Benidipine. |
| Simendan | Eperisone may increase the arrhythmogenic activities of Simendan. |
| Otilonium | Eperisone may increase the arrhythmogenic activities of Otilonium. |
| Nizofenone | Eperisone may increase the arrhythmogenic activities of Nizofenone. |
| Bunaftine | Eperisone may increase the arrhythmogenic activities of Bunaftine. |